Deciphering endothelial heterogeneity in health and disease at single-cell resolution: progress and perspectives

Abstract Endothelial cells (ECs) constitute the inner lining of vascular beds in mammals and are crucial for homeostatic regulation of blood vessel physiology, but also play a key role in pathogenesis of many diseases, thereby representing realistic therapeutic targets. However, it has become eviden...

Full description

Saved in:
Bibliographic Details
Published inCardiovascular research Vol. 119; no. 1; pp. 6 - 27
Main Authors Becker, Lisa M, Chen, Shiau-Haln, Rodor, Julie, de Rooij, Laura P M H, Baker, Andrew H, Carmeliet, Peter
Format Journal Article
LanguageEnglish
Published US Oxford University Press 17.03.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract Endothelial cells (ECs) constitute the inner lining of vascular beds in mammals and are crucial for homeostatic regulation of blood vessel physiology, but also play a key role in pathogenesis of many diseases, thereby representing realistic therapeutic targets. However, it has become evident that ECs are heterogeneous, encompassing several subtypes with distinct functions, which makes EC targeting and modulation in diseases challenging. The rise of the new single-cell era has led to an emergence of studies aimed at interrogating transcriptome diversity along the vascular tree, and has revolutionized our understanding of EC heterogeneity from both a physiological and pathophysiological context. Here, we discuss recent landmark studies aimed at teasing apart the heterogeneous nature of ECs. We cover driving (epi)genetic, transcriptomic, and metabolic forces underlying EC heterogeneity in health and disease, as well as current strategies used to combat disease-enriched EC phenotypes, and propose strategies to transcend largely descriptive heterogeneity towards prioritization and functional validation of therapeutically targetable drivers of EC diversity. Lastly, we provide an overview of the most recent advances and hurdles in single EC OMICs.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Conflict of interest: P.C. is named as an inventor on patent applications related to results discussed in this review.
Andrew H. Baker and Peter Carmeliet are co-corresponding authors.
Lisa M. Becker, Shiau-Haln Chen, Julie Rodor and Laura P.M.H. de Rooij contributed equally as first authors.
ISSN:0008-6363
1755-3245
DOI:10.1093/cvr/cvac018